Skip to content

Revograf

Generic Name
Mycophenolate Mofetil
Therapeutic Area
Nephrology
Therapeutic Class
Immunosuppressant
Dosage Form
Tablets
Strength
500 mg
Pack Size
50's
Registration Number
85984

Overview

Revograf tablets are indicated for the prophylaxis of acute organ rejection and for the treatment of refractory organ rejection in patients receiving allogeneic renal transplants. Revograf tablets are indicated for the prophylaxis of acute organ rejection and increased graft and patient survival in patients receiving allogeneic cardiac transplants. Revograf is indicated for the prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants. Revograf should be used concomitantly with cyclosporin and corticosteroids

Indication

-Prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplant -Concomitantly used with cyclosporine and corticosteroids